Американское общество гирудотерапии

Diverse molecular data demonstrate that commercially available medicinal leeches are not Hirudo medicinalis

Research article published in Proceedings. Biological sciences (2007)

Последнее обновление: March 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Геномика и протеомикаФармакология секрета слюнных желёзSiddall M et al. · Proceedings. Biological sciences, 2007

Abstract

The European medicinal leech is one of vanishingly few animal species with direct application in modern medicine. In addition to the therapeutic potential held by many protease inhibitors purified from leech saliva, and notwithstanding the historical association with quackery, Hirudo medicinalis has been approved by the United States Food and Drug Administration as a prescription medical device. Accurate annotation of bioactive compounds relies on precise species determination. Interpretations of developmental and neurophysiological characteristics also presuppose uniformity within a model species used in laboratory settings. Here, we show, with mitochondrial sequences and nuclear microsatellites, that there are at least three species of European medicinal leech, and that leeches marketed as H. medicinalis are actually Hirudo verbana. Beyond the obvious need for reconsideration of decades of biomedical research on this widely used model organism, these findings impact regulatory statutes and raise concerns for the conservation status of European medicinal leeches.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
Indexed MeSH termsAllelesAnalysis of VarianceAnimalsBase SequenceCommerceDNA PrimersDNA, MitochondrialEuropeLeechesMicrosatellite RepeatsModels, GeneticMolecular Sequence Data

Резюме

The European medicinal leech is one of vanishingly few animal species with direct application in modern medicine. In addition to the therapeutic potential held by many protease inhibitors purified from leech saliva, and notwithstanding the historical association with quackery, Hirudo medicinalis has been cleared by the United States FDA via 510(k) premarket notification...

Почему это важно для гирудотерапии

Expands the genomic and molecular understanding of medicinal leeches and their bioactive repertoire.

Цитирование

Diverse molecular data demonstrate that commercially available medicinal leeches are not Hirudo medicinalis.

Siddall M et al. · Proceedings. Biological sciences, 2007

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Добавлено в библиотеку ASH: March 18, 2026 · Последнее обновление сайта: March 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.

Diverse molecular data demonstrate that commercially available medicinal leeches are not Hirudo medicinalis | ASH